Team:Paris Bettencourt/Overview
From 2012.igem.org
(Difference between revisions)
(→General Design) |
|||
Line 23: | Line 23: | ||
We strived to make our system as robust against mutations as possible. | We strived to make our system as robust against mutations as possible. | ||
- | == | + | <table id="tableboxed" style="border-color:rgb(176,18,31);"> |
- | + | <tr> | |
+ | <td> | ||
+ | blah | ||
+ | </td> | ||
+ | </tr> | ||
+ | </table> | ||
===Step 1=== | ===Step 1=== | ||
[[File:Paris_Bettencourt_2012_General_Circuit_s1.gif|center|550px|Step 1.]] | [[File:Paris_Bettencourt_2012_General_Circuit_s1.gif|center|550px|Step 1.]] |
Revision as of 10:41, 26 September 2012
Project Overview
Contents |
Objectives
Our project aims to:
- Raise the issue of biosafety, and advocate the discerning use of biosafety circuits in future iGEM projects as a requirement
- Evaluate the risk of HGT in different SynBio applications
- Develop a new, improved containment system to expand the range of environments where GEOs can be used safely.
To do so, we:
- Engaged the general public and scientific community through debate
- Raised the question about how we can regulate this practices
- Compiled a parts page of safety circuits in the registry
- Relied on three levels of containment :
- Physical containment with alginate capsules
- Semantic containment using an amber suppressor system
- An improved killswitch featuring delayed population-level suicide through complete genome degradation.
We strived to make our system as robust against mutations as possible.
blah |
Step 1
Step 2
Step 2.
Step 3
Step 3.